QuarterHawk — Equity ResearchQuarterHawk — Equity Research

Spok Holdings, Inc. (SPOK)

Healthcare

No action
Fundamental
4
Sentiment
3
Technical
3

Do Nothing: avgDollarVolume20 is about $1.69M, below the $5M liquidity floor, and recent 3-session regular-session dollar volume is about $1.15M, below the $1.5M recent-liquidity floor.

Analysis as of 2026-08-11· more than 2 trading days ago

Company overview

Spok Holdings, Inc. provides advanced communication solutions primarily for the healthcare sector, operating through its subsidiary, Spok, Inc. The company offers messaging services, voicemail functionalities, and the Spok Care Connect platform to streamline clinician workflows. It serves a diverse clientele including healthcare providers, businesses, and government entities.

Fundamental

good
Fundamental4
Solid fundamentals

Spok is profitable with strong cash flow and low leverage, but faces growth challenges in its wireless segment.

Spok is profitable and cash-generative with net cash, low volatility (beta ~0.45), and solid solvency (Altman Z-score ~3.79) in recent SEC filings (no going-concern language). Valuation is reasonable (P/E ~18.97, EV/EBITDA ~9.78) and free-cash-flow yield is attractive (~10.76%), but growth is muted as wireless revenue declines despite software expansion. FundamentalScore: 4/5.

Sentiment

fair
Sentiment3
Mixed sentiment

Sentiment is mildly positive post-earnings, but lacks clear forward catalysts and retail engagement.

Near-term coverage is modestly positive around Spok’s Q2’26 results (record adj. EBITDA/software bookings) but broader 30–90d sentiment is indeterminate due to a baseline pull that returned no primary-tier items, and there are no clearly identified forward catalysts within the next month. No regulator-confirmed investigations surfaced (cases search hit a CAPTCHA), so no red-flag cap was applied.

Technical

fair
Technical3
Thin volume

Short-term technicals show strength above key averages, but low liquidity limits trading potential.

Short-term trend is constructive with price above the SMA20, SMA50, EMA9, and EMA21, MACD above zero, and ADX near 59, but the stock is still below the SMA200 and participation is too light to grade beyond a mixed score.

You’re looking at 2026-08-11 — more than 2 trading days ago.

Subscribers saw this then, and see today’s score, verdict and trade plan now.

Not financial advice. For informational and educational purposes only.